Stocks and securities in focus
| Security | Change (%) ▼ | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Adaptimmune Therapeutics PLC ADR | 15.980% | -30.165% | -36.940% | -33.465% | 35.200% | -79.490% | - |
| ProQR Therapeutics N.V. | 10.950% | -3.022% | -9.833% | 3.112% | 14.749% | -58.920% | - |
| Endo International | 10.000% | 57.143% | 10.000% | -92.143% | -72.500% | -99.779% | -99.824% |
| Synthetic Biologics Inc. | 4.290% | 1.220% | -0.240% | -37.121% | 3.750% | -90.653% | -92.655% |
| Viracta Therapeutics Inc. | 4.140% | - | - | - | - | - | - |
| Vanda Pharmaceuticals | 2.990% | 17.000% | 33.714% | -17.895% | 20.619% | -65.075% | - |
| Inotiv Inc. | 2.710% | -28.710% | -46.098% | 4.739% | 34.756% | - | - |
| NanoViricides Inc. | 1.890% | -7.692% | 3.846% | -14.961% | 14.286% | -69.457% | -76.794% |
| Salarius Pharmaceuticals Inc. | 1.850% | 10.553% | -19.266% | -71.613% | -20.721% | -98.176% | -99.994% |
| Ocuphire Pharma Inc. | 1.320% | -1.205% | -6.606% | -70.182% | -41.324% | - | - |
| MacroGenics Inc. | 1.130% | -9.038% | 9.790% | 151.200% | 74.444% | -40.799% | - |
| Johnson & Johnson | 0.790% | -1.269% | -5.049% | -6.730% | -3.305% | 1.093% | 11.844% |
| Heron Therapeutics Inc. | 0.710% | 0.157% | -6.250% | 4.508% | 62.420% | -82.770% | - |
| Teva Pharmaceutical Industries Ltd ADR | 0.410% | -6.589% | -1.633% | 54.884% | 29.292% | 34.187% | -6.950% |
| Merck & Co. Inc. | 0.340% | 0.000% | 5.188% | 12.214% | 19.391% | 81.903% | 80.313% |
| Sartorius AG ST | 0.000% | -20.151% | -22.344% | -33.228% | -19.697% | -49.222% | 53.069% |
| Novo Nordisk A/S | -0.080% | - | - | - | - | - | - |
| Immuron | -0.910% | -14.844% | -6.034% | 21.788% | 30.539% | -50.679% | - |
| Ardelyx Inc. | -1.020% | -12.086% | -15.475% | 35.391% | 4.706% | -16.524% | - |
| Immunic Inc. | -1.180% | -9.618% | -2.951% | -19.565% | -17.203% | -90.067% | - |
| Evolus Inc | -1.830% | -7.627% | -15.504% | 39.744% | 16.578% | 15.344% | - |
| Cidara Therapeutics Inc | -1.830% | -15.584% | 5.324% | -33.480% | -7.143% | -61.872% | - |
| Eli Lilly Corp. | -1.880% | -1.032% | -0.455% | 107.681% | 32.633% | 343.368% | 580.961% |
| Fate Therapeutics Inc. | -1.880% | -14.595% | -26.874% | -16.608% | 33.296% | -93.009% | - |
| Enlivex Therapeutics Ltd. | -2.100% | -61.326% | -61.111% | -46.970% | -37.500% | -84.358% | - |
| Sutro Biopharma Inc | -2.230% | -17.062% | -2.235% | -16.667% | -9.794% | -80.000% | - |
| Larimar Therapeutics Inc. | -2.500% | 2.344% | -17.610% | 53.037% | 54.481% | -54.828% | - |
| Abeona Therapeutics Inc. | -2.820% | 2.899% | 10.248% | 183.094% | 50.743% | -77.389% | - |
| Deciphera Pharmaceuticals | -3.650% | -7.042% | -2.798% | -5.138% | -10.174% | -64.894% | - |
| Zoetis Inc. A | -3.770% | -5.156% | -8.411% | -9.563% | -19.100% | 2.816% | 63.102% |